On 30 August 2011, orphan designation (EU/3/11/898) was granted by the European Commission to Santen Oy, Finland, for sirolimus for the treatment of chronic non-infectious uveitis.
|Disease / condition||
Treatment of chronic non-infectious uveitis
|Date of first decision||
|EU designation number||
Review of designation
The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.